US 11142765
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted A61PA61P21/00A61P27/02
Quick answer
US patent 11142765 (Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof) held by Benitec IP Holdings Inc. expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Benitec IP Holdings Inc.
- Grant date
- Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P21/00, A61P27/02